IL56239A - Pharmaceutical compositions comprising certain 1,3-bis-2-carboxy chromonyloxy-2-hydroxypropane salts - Google Patents

Pharmaceutical compositions comprising certain 1,3-bis-2-carboxy chromonyloxy-2-hydroxypropane salts

Info

Publication number
IL56239A
IL56239A IL56239A IL5623978A IL56239A IL 56239 A IL56239 A IL 56239A IL 56239 A IL56239 A IL 56239A IL 5623978 A IL5623978 A IL 5623978A IL 56239 A IL56239 A IL 56239A
Authority
IL
Israel
Prior art keywords
chromonyloxy
hydroxypropane
carboxy
bis
salts
Prior art date
Application number
IL56239A
Other versions
IL56239A0 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IL56239A0 publication Critical patent/IL56239A0/en
Publication of IL56239A publication Critical patent/IL56239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL56239A 1977-12-23 1978-12-18 Pharmaceutical compositions comprising certain 1,3-bis-2-carboxy chromonyloxy-2-hydroxypropane salts IL56239A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53825/77A GB1595220A (en) 1977-12-23 1977-12-23 Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Publications (2)

Publication Number Publication Date
IL56239A0 IL56239A0 (en) 1979-03-12
IL56239A true IL56239A (en) 1983-02-23

Family

ID=10469110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL56239A IL56239A (en) 1977-12-23 1978-12-18 Pharmaceutical compositions comprising certain 1,3-bis-2-carboxy chromonyloxy-2-hydroxypropane salts

Country Status (18)

Country Link
JP (1) JPS5489016A (en)
AU (1) AU523616B2 (en)
BE (1) BE872918A (en)
CA (1) CA1108992A (en)
CH (1) CH641349A5 (en)
DE (1) DE2855001A1 (en)
DK (1) DK568278A (en)
FI (1) FI783897A7 (en)
FR (1) FR2412310A1 (en)
GB (1) GB1595220A (en)
IE (1) IE47539B1 (en)
IL (1) IL56239A (en)
IT (1) IT7831068A0 (en)
LU (1) LU80721A1 (en)
NL (1) NL7812344A (en)
NZ (1) NZ189255A (en)
SE (1) SE7813062L (en)
ZA (1) ZA787155B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116017B2 (en) * 1986-05-17 1995-12-13 アース製薬株式会社 Bath additive
GB9824604D0 (en) * 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
WO2002045684A2 (en) * 2000-12-06 2002-06-13 Pharmacia Corporation Rapidly dispersing pharmaceutical composition comprising effervescent agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2132521A1 (en) * 1971-04-06 1972-11-24 Sofrader Sa Effervescent tablets prdn - by controlled drying in effervescent granule formation
GB1423985A (en) * 1972-02-15 1976-02-04 Fisons Ltd Pharmaceutical compositions containing bischromonyloxy compounds
GB1517153A (en) * 1974-11-30 1978-07-12 Fisons Ltd Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof
GB1570993A (en) * 1976-05-21 1980-07-09 Fisons Ltd Pharmaceutical tablet formulation
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory

Also Published As

Publication number Publication date
SE7813062L (en) 1979-06-24
DK568278A (en) 1979-06-24
IL56239A0 (en) 1979-03-12
IE47539B1 (en) 1984-04-18
LU80721A1 (en) 1979-09-07
DE2855001A1 (en) 1979-07-05
AU523616B2 (en) 1982-08-05
NZ189255A (en) 1984-05-31
FR2412310B1 (en) 1982-12-31
IE782540L (en) 1979-06-23
CA1108992A (en) 1981-09-15
NL7812344A (en) 1979-06-26
ZA787155B (en) 1979-12-27
CH641349A5 (en) 1984-02-29
FI783897A7 (en) 1979-06-24
AU4265478A (en) 1979-06-28
IT7831068A0 (en) 1978-12-20
FR2412310A1 (en) 1979-07-20
JPS5489016A (en) 1979-07-14
GB1595220A (en) 1981-08-12
BE872918A (en) 1979-06-20

Similar Documents

Publication Publication Date Title
ZA781398B (en) Pharmaceutical compositions
KE3525A (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
ZA771091B (en) Pharmaceutical compositions
AU3111677A (en) Pharmaceutical compositions
GB2032776B (en) Compositions comprising 4,5-dianisylthiazoles
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
IL56248A (en) 4-spectinomycylamine and salts thereof,their preparation and pharmaceutical compositions containing them
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ188946A (en) 1,2-benzisoxazoloxyacetic acid derivatives pharmaceutical compositions
GB2008403B (en) Pharmaceutical compositions
ZM1878A1 (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
AU2609277A (en) Pharmaceutical compositions
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL53685A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutical salts thereof,process for their preparation and pharmaceutical compositions containing them
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
AU3217178A (en) 1,1'-bis-biguanide compositions
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
ZA772612B (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
GB1547206A (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition